Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Molecular Psychiatry
|
March 31, 2010
Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder
D M Cannon, J K Klaver, S K Gandhi, et al.
Psychiatry Research
|
July 26, 2015
Altered threat and safety neural processing linked to persecutory delusions in schizophrenia: a two-task fMRI study
David L Perez, Hong Pan, Daniel S Weisholtz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Molecular Psychiatry
|
December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
Luca Sforzini, Courtney Worrell, Melisa Kose, et al.
Molecular Psychiatry
|
May 3, 2017
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
D P Hibar, L T Westlye, N T Doan, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Molecular Psychiatry
|
March 31, 2010
Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder
D M Cannon, J K Klaver, S K Gandhi, et al.
Psychiatry Research
|
July 26, 2015
Altered threat and safety neural processing linked to persecutory delusions in schizophrenia: a two-task fMRI study
David L Perez, Hong Pan, Daniel S Weisholtz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Molecular Psychiatry
|
December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
Luca Sforzini, Courtney Worrell, Melisa Kose, et al.
Molecular Psychiatry
|
May 3, 2017
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
D P Hibar, L T Westlye, N T Doan, et al.
Page
of 4